217 related articles for article (PubMed ID: 18541402)
1. Effect of Gb3 in lipid rafts in resistance to Shiga-like toxin of mutant Vero cells.
Hanashima T; Miyake M; Yahiro K; Iwamaru Y; Ando A; Morinaga N; Noda M
Microb Pathog; 2008 Aug; 45(2):124-33. PubMed ID: 18541402
[TBL] [Abstract][Full Text] [Related]
2. Receptor affinity, stability and binding mode of Shiga toxins are determinants of toxicity.
Shimizu T; Sato T; Kawakami S; Ohta T; Noda M; Hamabata T
Microb Pathog; 2007; 43(2-3):88-95. PubMed ID: 17532600
[TBL] [Abstract][Full Text] [Related]
3. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.
Watanabe M; Matsuoka K; Kita E; Igai K; Higashi N; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K
J Infect Dis; 2004 Feb; 189(3):360-8. PubMed ID: 14745692
[TBL] [Abstract][Full Text] [Related]
4. Binding of Escherichia coli verotoxins to cell surface protein on wild-type and globotriaosylceramide-deficient Vero cells.
Devenish J; Gyles C; LaMarre J
Can J Microbiol; 1998 Jan; 44(1):28-34. PubMed ID: 9522446
[TBL] [Abstract][Full Text] [Related]
5. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3.
Ling H; Boodhoo A; Hazes B; Cummings MD; Armstrong GD; Brunton JL; Read RJ
Biochemistry; 1998 Feb; 37(7):1777-88. PubMed ID: 9485303
[TBL] [Abstract][Full Text] [Related]
6. Enhanced low shear stress induced platelet aggregation by Shiga-like toxin 1 purified from Escherichia coli O157.
Yagi H; Narita N; Matsumoto M; Sakurai Y; Ikari H; Yoshioka A; Kita E; Ikeda Y; Titani K; Fujimura Y
Am J Hematol; 2001 Feb; 66(2):105-15. PubMed ID: 11421288
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Vero cell cytotoxic activity in Escherichia coli O157:H7 lysates by globotriaosylceramide, Gb3, from bovine milk.
Watarai S; Tana ; Inoue K; Kushi Y; Isogai E; Yokota K; Naka K; Oguma K; Kodama H
Biosci Biotechnol Biochem; 2001 Feb; 65(2):414-9. PubMed ID: 11302178
[TBL] [Abstract][Full Text] [Related]
8. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.
Müthing J; Schweppe CH; Karch H; Friedrich AW
Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility to verotoxin as a function of the cell cycle.
Pudymaitis A; Lingwood CA
J Cell Physiol; 1992 Mar; 150(3):632-9. PubMed ID: 1537890
[TBL] [Abstract][Full Text] [Related]
10. Application of combined high-performance thin-layer chromatography immunostaining and nanoelectrospray ionization quadrupole time-of-flight tandem mass spectrometry to the structural characterization of high- and low-affinity binding ligands of Shiga toxin 1.
Meisen I; Friedrich AW; Karch H; Witting U; Peter-Katalinić J; Müthing J
Rapid Commun Mass Spectrom; 2005; 19(24):3659-65. PubMed ID: 16285017
[TBL] [Abstract][Full Text] [Related]
11. Fabry disease in mice protects against lethal disease caused by Shiga toxin-expressing enterohemorrhagic Escherichia coli.
Cilmi SA; Karalius BJ; Choy W; Smith RN; Butterton JR
J Infect Dis; 2006 Oct; 194(8):1135-40. PubMed ID: 16991089
[TBL] [Abstract][Full Text] [Related]
12. Escherichia coli serogroup O107/O117 lipopolysaccharide binds and neutralizes Shiga toxin 2.
Gamage SD; McGannon CM; Weiss AA
J Bacteriol; 2004 Aug; 186(16):5506-12. PubMed ID: 15292153
[TBL] [Abstract][Full Text] [Related]
13. Binding of avian ovomucoid to shiga-like toxin type 1 and its utilization for receptor analog affinity chromatography.
Miyake M; Utsuno E; Noda M
Anal Biochem; 2000 Jun; 281(2):202-8. PubMed ID: 10870836
[TBL] [Abstract][Full Text] [Related]
14. Single-step method for purification of Shiga toxin-1 B subunit using receptor-mediated affinity chromatography by globotriaosylceramide-conjugated octyl sepharose CL-4B.
Nakajima H; Katagiri YU; Kiyokawa N; Taguchi T; Suzuki T; Sekino T; Mimori K; Saito M; Nakao H; Takeda T; Fujimoto J
Protein Expr Purif; 2001 Jul; 22(2):267-75. PubMed ID: 11437603
[TBL] [Abstract][Full Text] [Related]
15. Shiga toxin binding to glycolipids and glycans.
Gallegos KM; Conrady DG; Karve SS; Gunasekera TS; Herr AB; Weiss AA
PLoS One; 2012; 7(2):e30368. PubMed ID: 22348006
[TBL] [Abstract][Full Text] [Related]
16. Human Gb3/CD77 synthase produces P1 glycotope-capped N-glycans, which mediate Shiga toxin 1 but not Shiga toxin 2 cell entry.
Szymczak-Kulus K; Weidler S; Bereznicka A; Mikolajczyk K; Kaczmarek R; Bednarz B; Zhang T; Urbaniak A; Olczak M; Park EY; Majorczyk E; Kapczynska K; Lukasiewicz J; Wuhrer M; Unverzagt C; Czerwinski M
J Biol Chem; 2021; 296():100299. PubMed ID: 33460651
[TBL] [Abstract][Full Text] [Related]
17. Blood group P1 antigen-bearing glycoproteins are functional but less efficient receptors of Shiga toxin than conventional glycolipid-based receptors.
Morimoto K; Suzuki N; Tanida I; Kakuta S; Furuta Y; Uchiyama Y; Hanada K; Suzuki Y; Yamaji T
J Biol Chem; 2020 Jul; 295(28):9490-9501. PubMed ID: 32409578
[TBL] [Abstract][Full Text] [Related]
18. Shiga toxin glycosphingolipid receptors of Vero-B4 kidney epithelial cells and their membrane microdomain lipid environment.
Steil D; Schepers CL; Pohlentz G; Legros N; Runde J; Humpf HU; Karch H; Müthing J
J Lipid Res; 2015 Dec; 56(12):2322-36. PubMed ID: 26464281
[TBL] [Abstract][Full Text] [Related]
19. Activation of Src family kinase yes induced by Shiga toxin binding to globotriaosyl ceramide (Gb3/CD77) in low density, detergent-insoluble microdomains.
Katagiri YU; Mori T; Nakajima H; Katagiri C; Taguchi T; Takeda T; Kiyokawa N; Fujimoto J
J Biol Chem; 1999 Dec; 274(49):35278-82. PubMed ID: 10575015
[TBL] [Abstract][Full Text] [Related]
20. Adamantyl globotriaosyl ceramide: a monovalent soluble mimic which inhibits verotoxin binding to its glycolipid receptor.
Mylvaganam M; Lingwood CA
Biochem Biophys Res Commun; 1999 Apr; 257(2):391-4. PubMed ID: 10198223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
